03:56 PM EST - Bradmer Pharmaceuticals Inc. : reported a first-quarter net loss of $2.2 million U.S. or $0.16 U.S. per share, compared to net loss of $3.2 million U.S. or $0.23 U.S. per share in the prior-year quarter. Research & development expenses for the quarter were $1.4 million U.S., compared to $2.3 million U.S. in the last-year quarter. Bradmer Pharmaceuticals Inc.
shares T.BMR are trading even at $0.19.
